BCL2 and acute myeloid leukemia: In this study, we explored the impact of inducing MNT loss in mouse and human AML cells that expressed MLL-fusion proteins and investigated whether MNT loss could enhance the response of these AMLs to BH3-mimetic drugs, which inhibit prosurvival members of the BCL-2 family.28